Adverts

Open Access Articles- Top Results for ABT-202

ABT-202

</th></tr>
ABT-202
240px
Systematic (IUPAC) name
(3S)-1-(pyridin-3-yl)pyrrolidin-3-amine
Clinical data
Identifiers
PubChem CID 39220800
ChemSpider 16397614 7pxY
Chemical data
Formula C9H13N3
163.219
 14pxY (what is this?)  (verify)

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2]

References

  1. ^ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000) 5 (1): 76–81. PMID 14983978.  edit
  2. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. PMID 17295372. doi:10.1002/cmdc.200600207.  edit

Template:Navbox with collapsible sections


Lua error in package.lua at line 80: module 'Module:Buffer' not found.